
Pierre Blanchard/X
May 3, 2025, 14:20
Pierre Blanchard: 10 year results of HYPO RT PC at ESTRO 2025
Pierre Blanchard, Radiation Oncology Clinical Section Chief at Gustave Roussy Cancer Institute, shared a post on X:
“10y results of HYPO RT PC at ESTRO 2025
Hypofractionated prostate cancer RT (42,7/7) vs conv fractionated RT
1. Non inferior for FFS (even better?)
2. Similar bPFS, DMFS, ADT use, OS
3. Similar GU/GI tox (except transient flare at 1y for UHF).”
ESTRO 2025 Live Updates on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 3, 2025, 14:20
May 3, 2025, 14:17
May 3, 2025, 14:11
May 3, 2025, 13:52
May 3, 2025, 13:15
May 3, 2025, 12:57